Diabetes in women - A life-course approach

Menopause International

Volumn 19, Issue 2, 2013, Pages 87-95

  Morling, Joanne R ^a   Balkau, Beverley ^b   Wild, Sarah H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Diabetes; Type 1; Type 2; Women

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GESTAGEN; GLIBENCLAMIDE; GROWTH HORMONE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LONG ACTING INSULIN; METFORMIN; METHYLDOPA;

ACNE; BLOOD PRESSURE; BONE DENSITY; BREAST CANCER; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ETHNICITY; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HORMONE SUBSTITUTION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; MAMMOGRAPHY; MENARCHE; MENOPAUSE; MENSTRUAL IRREGULARITY; NAUSEA AND VOMITING; NEOPLASM; NEWBORN DEATH; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OLIGOMENORRHEA; OOCYTE MATURATION; OSTEOPOROSIS; OVARY CANCER; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREVALENCE; PUBERTY; RETINOPATHY; REVIEW; SEX DIFFERENCE; URINE INCONTINENCE; UTERINE CERVIX CANCER; VAGINAL DRYNESS; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

EID: 84890187653     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1177/1754045313487719     Document Type: Review

References (73)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes. Diabetes Care 2004; 27(5): 1047-1053.
2. Logue J, Walker J, Colhoun H, et al. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia 2011; 54(12): 1-4.
3. Scottish Diabetes Group. Scottish Diabetes Survey Monitoring Group, Scotland. Scottish Executive. Scottish diabetes survey. [Edinburgh]: Scottish Executive; 2010. p. v.
4. Scottish Diabetes Group. Scottish Diabetes Survey Monitoring Group., Scotland. Scottish Executive. Scottish Diabetes Survey 2009. [Edinburgh]: Scottish Executive; 2009.
5. Walker JJ, Livingstone SJ, Colhoun HM, et al. Effect of socioeconomic status on mortality among people with type 2 diabetes. Diabetes Care 2011; 34(5): 1127-1132.
6. Ahmed RG. Evolutionary interactions between diabetes and development. Diabetes Res Clin Pract 2011; 92(2): 153-167.
7. Dorman JS, Steenkiste AR, Foley TP, et al. Menopause in type 1 diabetic women: is it premature? Diabetes 2001; 50(8): 1857-1862.
8. Ahmed ML, Connors MH, Drayer NM, et al. Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age [Erratum appears in Diabetes Care 1998; 21(8): 1382]. Diabetes Care 1998; 21(5): 831-835.
9. Codner E, Barrera A, Mook-Kanamori D, et al. Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type-1 diabetes mellitus. Pediatr Diabetes 2004; 5(4): 182-189.
10. Bryden KS, Neil A, Mayou RA, et al. Eating habits, body weight, and insulin misuse. A longitudinal study of teenagers and young adults with type 1 diabetes. Diabetes Care 1999; 22(12): 1956-1960.
11. Shim U, Oh J-Y, Lee HJ, et al. Long menstrual cycle is associated with type 2 diabetes mellitus in Korean women. Diabetes Metab J 2011; 35(4): 384-389.
12. Gast G-CM, Grobbee DE, Smit HA, et al. Menstrual cycle characteristics and risk of coronary heart disease and type 2 diabetes. Fertil Steril 2010; 94(6): 2379-2381.
13. Lakshman R, Forouhi N, Luben R, et al. Association between age at menarche and risk of diabetes in adults: results from the EPIC-Norfolk cohort study. Diabetologia 2008; 51(5): 781-786.
14. He C, Zhang C, Hunter DJ, et al. Age at menarche and risk of type 2 diabetes: results from 2 large prospective cohort studies. Am J Epidemiol 2010; 171(3): 334-344.
15. Pierce MB, Kuh D and Hardy R. The role of BMI across the life course in the relationship between age at menarche and diabetes, in a British Birth Cohort. Diabetic Med 2012; 29(5): 600-603.
16. Moran LJ, Misso ML, Wild RA, et al. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reprod Update 2010; 16(4): 347-363.
17. Moran LJ, Hutchison SK, Norman RJ, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011; (7): CD007506.
18. Costello M, Shrestha B, Eden J, et al. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database Syst Rev 2007; (1): CD005552.
19. NHS National Services Scotland. Births in Scottish Hospitals: year ending 31st March 2011. In: Information Services Division, editor. NHS National Services Scotland, Edinburgh, http://www.isdscotland.org/Health-Topics/Maternity-and-Births/Publications/2012-11-27/2012-11-27-Births-Report.pdf?38163393736 (2012, accessed 04 March 2013).
20. Whitworth KW, Baird DD, Stene LC, et al. Fecundability among women with type 1 and type 2 diabetes in the Norwegian Mother and Child Cohort Study. Diabetologia 2011; 54(3): 516-522.
21. Diabetes Control and Complications Trial Research G. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care 2000; 23(8): 1084-1091.
22. Klein BE, Moss SE and Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care 1990; 13(1): 34-40.
23. Buchanan T, Xiang A and Page K. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol 2012; 8(11): 639-649.
24. Ali S and Dornhorst A. Diabetes in pregnancy: health risks and management. Postgrad Med J 2011; 87(1028): 417-427.
25. Suhonen L, Hiilesmaa V and Teramo K. Glycaemic control during early pregnancy and fetal malformations in women with type I diabetes mellitus. Diabetologia 2000; 43(1): 79-82.
26. Guerin A, Nisenbaum R and Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 2007; 30(7): 1920-1925.
27. Confidential Enquiry into Maternal and Child Health. Pregnancy in women with type 1 and type 2 diabetes in 2002-03, England, Wales and Northern Ireland. London: CEMACH; 2005.
28. Simmons D. Metformin treatment for type 2 diabetes in pregnancy? Best Pract Res Clin Endocrinol Metabol 2010; 24(4): 625-634.
29. Simmons D. Diabetes and obesity in pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25(1): 25-36.
30. Mathiesen ER, Ringholm L and Damm P. Pregnancy management of women with pregestational diabetes. Endocrinol Metabol Clin North Am 2011; 40(4): 727-738.
31. McCance DR, Maresh M and Sacks DA. A practical manual of diabetes in pregnancy. Oxford: Wiley- Blackwell, 2010, pp.99-109.
32. Sjoberg L, Pitkaniemi J, Harjutsalo V, et al. Menopause in women with type 1 diabetes. Menopause 2011; 18(2): 158-163.
33. Malacara JM, Huerta R, Rivera B, et al. Menopause in normal and uncomplicated NIDDM women: physical and emotional symptoms and hormone profile. Maturitas 1997; 28(1): 35-45.
34. Lopez-Lopez R, Huerta R and Malacara JM. Age at menopause in women with type 2 diabetes mellitus. Menopause 1999; 6(2): 174-178.
35. Kim C, Edelstein SL, Crandall JP, et al. Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause 2011; 18(8): 857-868.
36. Brand JS, van der Schouw YT, Onland-Moret NC, et al. Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study. Diabetes Care 2013; 36(4): 1012-1019.
37. Salpeter SR, Walsh JME, Ormiston TM, et al. Metaanalysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006; 8(5): 538-554.
38. Norhammar A and Schenck-Gustafsson K. Type 2 diabetes and cardiovascular disease in women. Diabetologia 2013; 56(1): 1-9.
39. Tunstall-Pedoe H. Myth and paradox of coronary risk and the menopause. Lancet 1998; 351(9113): 1425-1427.
40. Vaidya D, Becker DM, Bittner V, et al. Ageing, menopause, and ischaemic heart disease mortality in England, Wales, and the United States: modelling study of national mortality data. BMJ 2011; 343: d5170.
41. The Emerging Risk Factors C. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375(9733): 2215-2222.
42. Kanaya AM, Grady D and Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 2002; 162(15): 1737-1745.
43. Nicodemus KK, Folsom AR and Iowa Women's Health S. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24(7): 1192-1197.
44. Schwartz AV. Diabetes mellitus: does it affect bone? Calcif Tissue Int 2003; 73(6): 515-519.
45. Inzerillo A and Epstein S. Osteoporosis and diabetes mellitus. Rev Endocr Metab Disord 2004; 5(3): 261-268.
46. Leidig-Bruckner G and Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes 2001; 109(Suppl 2): S493-S514.
47. Loke YK, Singh S and Furberg CD. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. Can Med Assoc J 2009; 180(1): 32-39.
48. La Vecchia C, Negri E, Franceschi S, et al. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70(5): 950-953.
49. Parazzini F, La Vecchia C, Negri E, et al. Diabetes and endometrial cancer: an Italian case-control study. Int J Cancer 1999; 81(4): 539-542.
50. Ogunleye AA, Ogston SA, Morris AD, et al. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009; 101(7): 1199-1201.
51. Zendehdel K, Nyren O, Ostenson C-G, et al. Cancer incidence in patients with type 1 diabetes mellitus: a population- based cohort study in Sweden. J Natl Cancer Inst 2003; 95(23): 1797-800.
52. Saltzman BS, Doherty JA, Hill DA, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 2008; 167(5): 607-614.
53. Marshall JG, Cowell JM, Campbell ES, et al. Regional variations in cancer screening rates found in women with diabetes. Nursing Res 2010; 59(1): 34-41.
54. Zhao G, Ford ES, Ahluwalia IB, et al. Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes. J Gen Intern Med 2009; 24(2): 270-275.
55. McBean AM and Yu X. The underuse of screening services among elderly women with diabetes. Diabetes Care 2007; 30(6): 1466-1472.
56. Lipscombe LL, Hux JE and Booth GL. Reduced screening mammography among women with diabetes. Arch Intern Med 2005; 165(18): 2090-2095.
57. Beckman TJ, Cuddihy RM, Scheitel SM, et al. Screening mammogram utilization in women with diabetes. Diabetes Care 2001; 24(12): 2049-2053.
58. Rollison DE, Giuliano AR, Sellers TA, et al. Populationbased case-control study of diabetes and breast cancer risk in Hispanic and non-Hispanic White women living in US southwestern states. Am J Epidemiol 2008; 167(4): 447-456.
59. Lipscombe L, Goodwin P, Zinman B, et al. Diabetes mellitus and breast cancer: a retrospective populationbased cohort study. Breast Cancer Res Treat 2006; 98(3): 349-356.
60. Michels KB, Solomon CG, Hu FB, et al. Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 2003; 26(6): 1752-1758.
61. Adami HO, McLaughlin J, Ekbom A, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2(5): 307-314.
62. Coughlin SS, Calle EE, Teras LR, et al. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159(12): 1160-1167.
63. Wolf I, Sadetzki S, Catane R, et al. Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6(2): 103-111.
64. Liao S, Li J, Wang L, et al. Type 2 diabetes mellitus and characteristics of breast cancer in China. Asian Pac J Cancer Prev 2010; 11(4): 933-937.
65. Wolf I, Sadetzki S, Gluck I, et al. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur J Cancer 2006; 42(8): 1077-1082.
66. Lipscombe L, Goodwin P, Zinman B, et al. The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 2008; 109(2): 389-395.
67. Erickson K, Patterson RE, Flatt SW, et al. Clinically defined type 2 diabetes mellitus and prognosis in earlystage breast cancer. J Clin Oncol 2011; 29(1): 54-60.
68. Adler AI, Weiss NS, Kamb ML, et al. Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States). Cancer Causes Control 1996; 7(4): 475-478.
69. Brinton LA, Sakoda LC, Frederiksen K, et al. Relationships of uterine and ovarian tumors to preexisting chronic conditions. Gynecol Oncol 2007; 107(3): 487-494.
70. Weiderpass E, Ye W, Vainio H, et al. Diabetes mellitus and ovarian cancer (Sweden). Cancer Causes Control 2002; 13(8): 759-764.
71. Parazzini F, Moroni S, La Vecchia C, et al. Ovarian cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 1997; 33(10): 1634-1637.
72. Swerdlow AJ, Laing SP, Qiao Z, et al. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 2005; 92(11): 2070-2075.
73. Bakhru A, Buckanovich RJ and Griggs JJ. The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol 2010; 121(1): 106-111.